XML 146 R79.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 71,107 $ 162,636
Short term marketable securities 106,427 0
Accounts receivables 0 21,011
Other receivables 14,297 3,482
Prepaid expenses and other current assets 527 18,476
Total current assets 192,358 205,605
Non-current assets:    
Restricted cash 30 20
Marketable securities 7,336 0
Property and equipment, net   43
Intangible assets   14,700
Goodwill 0 13,064
Long term prepaid expenses   7,192
Other assets   123
Total non-current assets 7,366 35,142
Total Assets 199,724 240,747
Current liabilities:    
Accounts payable 514 2,853
Accrued expenses 33,800 8,255
Other current liabilities 381 460
Total current liabilities 34,695 11,568
Non-current liabilities:    
Contingent consideration   52,000
Deferred tax liability   3,969
Deferred revenue   1,500
Total non-current liabilities   57,469
Total Liabilities $ 34,695 69,037
Stockholders' Equity:    
Preferred stock, $0.001 par value per share; 5,000,000 shares authorized at September 30, 2022 and December 31, 2021; no shares issued and outstanding at September 30, 2022 and December 31, 2021   $ 0
Common stock, shares outstanding (in shares) 202,757,012 199,463,645
Common stock, $0.001 par value per share; 400,000,000 shares authorized at September 30, 2022 and December 31, 2021; 202,757,012 and 199,463,645 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively $ 202 $ 199
Additional paid-in capital 493,629 487,768
Other comprehensive loss (235) 0
Accumulated deficit (328,567) (316,257)
Total Stockholders' Equity 165,029 171,710
Total Liabilities and Stockholders' Equity $ 199,724 $ 240,747
Common stock, shares issued (in shares) 202,757,012 199,463,645